Condition: Temporomandibular Disorders (TMD) · Internal Derangement of the Tempromandibular Joint · Anterior Disc Displacement · Sponsor: Horus University
This study aims to rigorously assess the effectiveness of LPCGF in the management of internal disc displacement in patients with TMD through a randomized clinical trial. By comparing LPCGF therapy with conventional arthrocentesis, this research looks to provide robust evidence on the efficacy, safety, and potential role of (LPCGF) as an alternative therapeutic choice for IDD.
This description comes directly from the study's public registry record.
Mohamed Ali Habib, Teaching assistant · +2001069505336 · mbasiouny@horus.edu.eg
Eman AbdElsalam Yousef, Associate professor · +20 15 56767533 · eabdelsalam@horus.edu.eg
Always discuss trial participation with your own doctor first.
| Faculty of Dentistry- Horus University in Egypt | Damietta, New Damietta, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07075276